Intracranial and Extracranial Vertebrobasilar Artery Stenosis Patient Profile in Dr. Moewardi General Hospital

Subandi Subandi, Suroto Suroto, Diah Kurnia Mirawati, Rivan Danuaji, Pepi Budianto, Yetty Hambarsari, Baarid Luqman Hamidi, Hanindia Riani Prabaningtyas, Ervina Arta Jayanti Hutabarat, Teddy Tejomukti, Ira Ristinawati, Raden Andi Ario Tedjo, Zefania Yonisa Pretikasari, Muhammad Hafizhan, Stefanus Erdana Putra

Abstract

Introduction: Vertebrobasilar artery stenosis can be extracranial or intracranial, and accounts for up to 20% of posterior circulation ischemic strokes. The gold standard for diagnosing is Digital Subtraction Angiography (DSA), an invasive diagnostic method by injecting a contrast agent into the blood vessels leading to the brain through a catheter. This study aims to determine the profile of patients with intracranial and extracranial vertebrobasilar artery stenosis who underwent DSA procedures.

Methods: This descriptive research was conducted in RSUD Dr. Moewardi in patients who underwent DSA procedures for the period January 2020 to March 2022 and found vertebrobasilar artery stenosis. The study samples were grouped based on the location of the stenosis; intracranial and extracranial. The data collected included age, gender, symptoms, risk factors, degree of stenosis, and angiographic findings.

Results: Of 42 subjects, 33 (78.6%) patients were male. There are 23 (54.8%) patients with intracranial vertebrobasilar stenosis and 19 (45.2%) patients in extracranial. The main symptoms included hemiparesis, vertigo, hemiesthesia, loss of consiciousness, aphasia, dysartria, and dysphagia. The risk factors were 36 (85.7%) patients with hypertension, 18 (42.9%) patients with diabetes mellitus, 18 (42.9%) patients with a history of smoking, and 13 (31%) patients with hyperlipidemia. A total of 8 patients underwent stenting/angioplasty.

Conclusion: The prevalence of vertebrobasilar artery stenosis increases with age, most commonly occurring at the age of 50-59 years..The most common risk factor for vertebrobasilar artery stenosis is hypertension. Management recommendations include a combination of antiplatelet and endovascular therapy.

Keywords

vertebrobasilar artery stenosis; Digital Subtraction Angiography (DSA)

Full Text:

PDF

References

1. Kelompok Studi Neurointervensi Perhimpunan Dokter Spesialis Saraf Indonesia. Konsensus Nasional Neurointervensi. Airlangga University Press. 2020;71-89.

2. Madonis SM, Jenkins JS. Vertebral artery stenosis. Prog Cardiovasc Dis. 2021;65:55–9.

3. Hass WK, Fields WS, North RR, Kircheff II, Chase NE, Bauer RB. Joint study of extracranial arterial occlusions. 11 Arteriography, techniques, sites, and complications. JAMA 1968;203:961968.

4. Caplan LR. The intracranial vertebral artery: A neglected species. Cerebrovasc Dis. 2012;34(1):20–30.

5. Kumar Dundamadappa S, Cauley K. Vertebral artery ostial stenosis: Prevalence by digital subtraction angiography, MR angiography, and CT angiography. J Neuroimaging. 2013;23(3):360–7.

6. Cloud GC, Markus HS. Diagnosis and management of vertebral artery stenosis. QJM - Mon J Assoc Physicians. 2003;96(1):27–34.

7. Caplan L, Wityk R, Pazdera L, Chang H-M, Pessin M, DeWitt L. New England Medical Center Posterior Circulation Stroke Registry II. Vascular Lesions. J Clin Neurol. 2005;1(1):31.

8. Wilkinson IM. The vertebral artery: extracranial and intracranial structure. Arch Neurol 1972; 27:392–6.

9. The WASID. study group. Prognosis of patients with symptomatic ver- tebral or basilar artery stenosis. The warfarin-aspirin symptomatic intra- cranial disease (WASID) study group. Stroke. 1998;29:1389–1392.

10. Gulli G, Khan S, Markus HS. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke. 2009;40(8):2732–7.

11. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis. Stroke. 2004;35(12):2902–9.

12. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. (2014) 383:333–41. doi: 10.1016/S0140-6736(13)62038-3

13. Li G, Yan P, Zhao Y, Li S, Xue Y, Xiang Y, et al. A Retrospective Study Comparison Between Stenting and Standardized Medical Treatment for Intracranial Vertebrobasilar Stenosis in a Real-World Chinese Cohort. Front Neurol. 2021;12(May):1–9.

14. Markus HS, Larsson SC, Kuker W, Schulz UG, Ford I, Rothwell PM, et al. Stenting for symptomatic vertebral artery stenosis. Neurology. 2017;89(12):1229–36.

15. Caplan LR, Saver J. Treatment. Dalam: Caplan LR, editor. Caplan’s Stroke A Clinical Approach Edisi 5 Cambridge University Press; 2016:145-190.

DOI: https://doi.org/10.13057/smj.v6i3.71299

Refbacks

  • There are currently no refbacks.